Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19

BACKGROUND: NK cells are the most active innate immune cells in antiviral immunity, which are impaired by SARS-COV2 infection. Infusion of allogeneic NK cells might be a complementary treatment to boost immune system function in COVID-19 patients. In this project, we focused on COVID-19 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadvand, Mohammad, Barough, Mahdieh Shokrollahi, Hashemi, Zahra Sadat, Sanati, Hassan, Abbasvandi, Fereshteh, Yunesian, Masud, Majidzadeh-A, Keivan, Makarem, Jalil, Aghayan, Hamid Reza, Abedini, Atefeh, Ghavamzadeh, Ardeshir, Forooshani, Ramin Sarrami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401743/
https://www.ncbi.nlm.nih.gov/pubmed/37542307
http://dx.doi.org/10.1186/s40814-023-01355-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401743/
https://www.ncbi.nlm.nih.gov/pubmed/37542307
http://dx.doi.org/10.1186/s40814-023-01355-6

Ejemplares similares